These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14593631)

  • 1. [Ring chromosome 20, hypersensitivity to valproate and hyperammonemic encephalopathy].
    Ortiz-Sáenz de Santa María MR; Barriuso-Pérez E; Soto-Alvarez MI; Moche-Loeri JA
    Rev Neurol; 2003 Oct 16-31; 37(8):733-5. PubMed ID: 14593631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children].
    Boldyreva SR; Ermakov AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):41-7. PubMed ID: 20517209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate enhances the risk of valproate-associated side effects in three children.
    Longin E; Teich M; Koelfen W; König S
    Epilepsia; 2002 Apr; 43(4):451-4. PubMed ID: 11952778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cognitive and behavioral effects of topiramate and valproate.
    Meador KJ; Loring DW; Hulihan JF; Kamin M; Karim R;
    Neurology; 2003 May; 60(9):1483-8. PubMed ID: 12743236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):39-44. PubMed ID: 20559266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic frontal lobe epilepsy in children].
    Boldyreva SR; Ermakov AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):58-65. PubMed ID: 20559276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
    Boldyreva SR; Ermakov AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):39-44. PubMed ID: 21322824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
    Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
    Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.